Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. (LSTA) — Form DEF 14A: Proxy statement
About this filing
Lisata Therapeutics, Inc. (LSTA) filed Form DEF 14A (proxy statement) with the SEC on Oct 19, 2026.
Key facts
- Document
- DEF 14A
More LSTA filings
- 8-K
Filed Nov 9, 2026
- ARS
Filed Oct 19, 2026
- 3
Filed Oct 15, 2026
- 8-K
Filed Oct 14, 2026
- PRE 14A
Filed Oct 7, 2026
- D
Filed Oct 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.